Summary:
A Phase 2, Randomized, Double-blind, Placebo-controlled Trial to Evaluate the Efficacy, Safety, and Tolerability of Darigabat in Participants With Panic Disorder
Qualified Participants Must:
• Be 18 - 65 years old
• Be diagnosed with panic disorder
• Have had a minimum of 8 panic attacks in the past month
• Additional criteria apply
Qualified Participants May Receive:
Up to $820 for time and travel